Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 38.14% is 71% above its 5-year average of 22.33%, near the high end of its 5-year range (7.58%–38.14%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.23% above its 12-month average of 29.74%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
38.14%
RETURN ON EQUITY (ROE) AVG TTM
29.74%
RETURN ON EQUITY (ROE) AVG 3Y
26.91%
RETURN ON EQUITY (ROE) AVG 5Y
22.33%
RETURN ON EQUITY (ROE) AVG 10Y
8.34%
RETURN ON EQUITY (ROE) AVG 15Y
-7.43%
RETURN ON EQUITY (ROE) AVG 20Y
-17.88%
CURRENT VS TTM AVG
+28.23%
CURRENT VS 3Y AVG
+41.73%
CURRENT VS 5Y AVG
+70.78%
CURRENT VS 10Y AVG
+357.42%
CURRENT VS 15Y AVG
+613.39%
CURRENT VS 20Y AVG
+313.30%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+193.13%
vs the sector median at left
DexCom, Inc.
Market Cap
$31.74B
Return on Equity (ROE)
38.14%
TTM Avg
29.74%
3Y Avg
26.91%
5Y Avg
22.33%
Market Cap
$31.90B
Return on Equity (ROE)
23.13%
TTM Avg
23.30%
3Y Avg
22.33%
5Y Avg
21.49%
Market Cap
$31.30B
Return on Equity (ROE)
4.43%
TTM Avg
8.42%
3Y Avg
11.86%
5Y Avg
16.52%
Market Cap
$31.13B
Return on Equity (ROE)
-22.60%
TTM Avg
-10.46%
3Y Avg
-1.37%
5Y Avg
1.10%
Market Cap
$30.88B
Return on Equity (ROE)
83.10%
TTM Avg
66.19%
3Y Avg
56.82%
5Y Avg
52.60%
Market Cap
$30.59B
Return on Equity (ROE)
1.09%
TTM Avg
29.98%
3Y Avg
64.02%
5Y Avg
111.55%
Market Cap
$29.76B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$29.34B
Return on Equity (ROE)
5.97%
TTM Avg
9.02%
3Y Avg
4.86%
5Y Avg
4.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DexCom, Inc. (DXCM) | $31.74B | 38.14% | 29.74% | 26.91% | 22.33% |
| ResMed Inc. (RMD)vs › | $31.90B | 23.13% | 23.30% | 22.33% | 21.49% |
| Biogen Inc. (BIIB)vs › | $31.30B | 4.43% | 8.42% | 11.86% | 16.52% |
| Centene Corp. (CNC)vs › | $31.13B | -22.60% | -10.46% | -1.37% | 1.10% |
| Zoetis Inc. (ZTS)vs › | $30.88B | 83.10% | 66.19% | 56.82% | 52.60% |
| Waters Corporation (WAT)vs › | $30.59B | 1.09% | 29.98% | 64.02% | 111.55% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.76B | 14.51% | 21.84% | 21.53% | 32.27% |
| Alcon Inc. (ALC)vs › | $33.72B | 2.96% | 4.58% | 3.90% | 2.45% |
| Medline Inc. (MDLN)vs › | $29.34B | 5.97% | 9.02% | 4.86% | 4.86% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.15B | 59.67% | -187.43% | 134.89% | 51.69% |
ROE
38.1%
ROA
15.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 38.14% |
| 2026-03-31 | 31.47% |
| 2025-12-31 | 30.46% |
| 2025-09-30 | 26.44% |
| 2025-06-30 | 22.21% |
| 2025-03-31 | 23.61% |
| 2024-12-31 | 27.40% |
| 2024-09-30 | 34.40% |
| 2024-06-30 | 27.40% |
| 2024-03-31 | 28.45% |
| 2023-12-31 | 26.18% |
| 2023-09-30 | 16.62% |
| 2023-06-30 | 17.02% |
| 2023-03-31 | 13.10% |
| 2022-12-31 | 16.01% |
| 2022-09-30 | 12.61% |
| 2022-06-30 | 8.85% |
| 2022-03-31 | 9.67% |
| 2021-12-31 | 7.58% |
| 2021-09-30 | 24.78% |
| 2021-06-30 | 26.56% |
| 2021-03-31 | 27.01% |
| 2020-12-31 | 27.02% |
| 2020-09-30 | 15.41% |
| 2020-06-30 | 15.12% |
| 2020-03-31 | 15.83% |
| 2019-12-31 | 11.45% |
| 2019-09-30 | -22.41% |
| 2019-06-30 | -24.77% |
| 2019-03-31 | -19.41% |
| 2018-12-31 | -19.16% |
| 2018-09-30 | 7.68% |
| 2018-06-30 | -1.12% |
| 2018-03-31 | -7.75% |
| 2017-12-31 | -11.97% |
| 2017-09-30 | -12.55% |
| 2017-06-30 | -18.38% |
| 2017-03-31 | -31.71% |
| 2016-12-31 | -23.11% |
| 2016-09-30 | -21.66% |
| 2016-06-30 | -32.63% |
| 2016-03-31 | -27.64% |
| 2015-12-31 | -26.04% |
| 2015-09-30 | -29.90% |
| 2015-06-30 | -12.01% |
| 2015-03-31 | -15.34% |
| 2014-12-31 | -15.98% |
| 2014-09-30 | -22.87% |
| 2014-06-30 | -27.21% |
| 2014-03-31 | -34.67% |
| 2013-12-31 | -35.43% |
| 2013-09-30 | -47.77% |
| 2013-06-30 | -64.93% |
| 2013-03-31 | -70.02% |
| 2012-12-31 | -70.78% |
| 2012-09-30 | -72.61% |
| 2012-06-30 | -59.45% |
| 2012-03-31 | -47.17% |
| 2011-12-31 | -42.82% |
| 2011-09-30 | -37.42% |
| 2011-06-30 | -34.90% |
| 2011-03-31 | -87.60% |
| 2010-12-31 | -90.45% |
| 2010-09-30 | -161.41% |
| 2010-06-30 | -138.99% |
| 2010-03-31 | -129.81% |
| 2009-03-31 | -365.28% |
| 2007-12-31 | -644.81% |
| 2007-09-30 | -258.15% |
| 2007-06-30 | -175.34% |
| 2007-03-31 | -128.04% |
| 2006-12-31 | -82.00% |
| 2006-09-30 | -71.74% |
| 2006-06-30 | -51.90% |
| 2006-03-31 | -88.63% |
| 2005-12-31 | -62.27% |
